2025-06-30Oakmark FundsBearOur bottom-up approach to a top-down crisis | U.S. equity market commentary 2Q 2025Detail →
2023-09-30Oakmark FundsBullOakmark Fund: Third Quarter 2023 and Fiscal Year-EndDetail →
2022-07-27Colossus (Invest Like the Best / Business Breakdowns)NeutralDuPont: Two Centuries of Chemistry - [Business Breakdowns, EP. 67]Detail →
2021-11-16Colossus (Invest Like the Best / Business Breakdowns)NeutralWill Marshall - Indexing the Earth - [Invest Like the Best, EP. 251]Detail →
2021-10-13Colossus (Invest Like the Best / Business Breakdowns)NeutralJohn Deere: Centuries of Farming Innovation [Business Breakdowns, EP. 30]Detail →
Earnings Callsⓘ
Q2 2026August 7, 2026
›
Quarterly results beat expectations, driven primarily by seed technology adoption and crop protection new product launches, leading management to raise full-year guidance.
First-half net sales +4% year-over-year to $11.3 billion; operating EBITDA +10% to $3.7 billion; operating EPS +14%.
The seed business delivered organic growth across all regions, with licensing revenue ahead of the original plan; crop protection new product volumes grew at high single digits, with pricing under pressure but productivity improvements driving margin expansion. The company is advancing the October 1 separation as planned, with both companies fully prepared.
Management raised full-year operating EBITDA guidance to $4.1–4.3 billion and EPS to $3.60–3.80, reflecting confidence in the second half.
Positive signals include management's optimistic tone, emphasizing strong execution and smooth separation progress; key risks are pricing competition in Brazil, tight farmer credit, and geopolitical uncertainty.